Amendment Statement of Principles concerning localised sclerosis (Reasonable Hypothesis) (No. 15 of 2019) (Cth)

Amendment Statement of Principles

concerning

LOCALISED SCLEROSIS
(Reasonable Hypothesis)

(No. 15 of 2019)

The Repatriation Medical Authority determines the following Amendment Statement of Principles under subsections 196B(2) and (8) of the Veterans' Entitlements Act 1986.

Dated      21 December 2018

The Common Seal of the
Repatriation Medical Authority
was affixed to this instrument
at the direction of:

Professor Nicholas Saunders AO
Chairperson

Contents

1Name........................................................................................................................................... 3

2Commencement........................................................................................................................ 3

3Authority..................................................................................................................................... 3

4Amendment............................................................................................................................... 3

1. Name

This is the Amendment Statement of Principles concerning localised sclerosis (Reasonable Hypothesis) (No. 15 of 2019).

1. Commencement

This instrument commences on 23 July 2018.

1. Authority

This instrument is made under subsections 196B(2) and (8) of the Veterans' Entitlements Act 1986.

1. Amendment

The Statement of Principles concerning localised sclerosis (Reasonable Hypothesis) (No. 61 of 2018) (Federal Register of Legislation No. F2018L00883) is amended in the following manner:

Section

Amendment

9(2)

Replace the existing factor in subsection 9(2) with the following:

being treated with a drug or a drug from a class of drugs from the specified list of drugs at the time of the clinical onset of localised sclerosis;

Note: specified list of drugs is defined in the Schedule 1 - Dictionary.

9(5)

Replace the existing factor in subsection 9(5) with the following:

being treated with a drug or a drug from a class of drugs from the specified list of drugs at the time of the clinical worsening of localised sclerosis;

Note: specified list of drugs is defined in the Schedule 1 - Dictionary.